US OptionsDetailed Quotes

OGN250516P12500

Watchlist

3.88
+0.17+4.58%

15min DelayTrading May 12 12:49 ET

3.90High3.70Low

Organon & Co Stock Discussion

Minerva2

May 7 03:07

$Organon & Co (OGN.US)$ I will start to buy the dip at 8.00. and add more by every 0.50 drop.

103237380

May 5 21:34

$Organon & Co (OGN.US)$ Top up time?

thedioyears

May 5 17:54

buy the dip?

$Organon & Co (OGN.US)$
Did not expect the dividend cut based on the comments provided on the last CC. Refresher "were committed to regular dividend as the number one capital allocation priority."
I'm glad Umer Raffat from Evercore ISI was able to straight up ask "how can we trust you?"
I understood their logic and managed to buy the "dip". You know what that means...
Lets see what Vtama can do.
As they said in the call, "The Vtama launch performance has been encouraging. As it c...

Minerva2

May 4 00:58

$Organon & Co (OGN.US)$ bought 100 shares at 9.30. buy more if goes down. i do not understand 87million dollar quarterly net income for a 2.5Billion market capital deserve a dump just because dividend goes from 0.28 to 0.02.

Teddy123

Apr 1 19:55

Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA® (tocilizumab) Injection, for Intravenous Infusion in the U.S.

$Organon & Co (OGN.US)$ $Biogen (BIIB.US)$
Organon Claims US Market Leadership with Groundbreaking Tocilizumab Biosimilar Deal

Teddy123

Mar 28 18:19

European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11

$Organon & Co (OGN.US)$
Major Win: Organon's Breast Cancer Drug Gets Critical EMA Validation After Trial Success

Daily Investors

Mar 10 20:56

OGN's PDUFA Date: A Potential Catalyst for a Cataclysmic Spike?
Tomorrow is a pivotal day for Organogenesis Holdings Inc. (OGN), a regenerative medicine company focused on wound care, surgical and sports medicine. The company is awaiting a decision from the U.S. Food and Drug Administration (FDA) on its Biologics License Application (BLA) for FortaFlex, a novel treatment for partial-thickness rotator cuff tears. This crucial juncture, known as the PDUFA date (Prescription Drug User Fee Act), cou...

Teddy123

Mar 8 22:59

New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Olde

$Organon & Co (OGN.US)$
Can This Skin Treatment Work for Months After Stopping? New Clinical Data Reveals Surprising Results

Jaguar8

Oct 28, 2024 21:26

NEWS

$Organon & Co (OGN.US)$
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%
The acquisition expands Organon's dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S.
BASEL, Switzerland and LONDON and NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Organon (NYSE: OGN), a global health...

Meltyy

Oct 11, 2024 14:22

🚨 M&A Update! 🚨

Keep an eye on these recently announced & closed M&As: 👀
🟢 Recently Announced:
⇒ $Organon & Co (OGN.US)$ to acquire Dermavant
⇒ $Rafael Holdings (RFL.US)$ to acquire Cyclo Tx
⇒Crown Lab to acquire $Revance Therapeutics(Delisted) (RVNC.US)$
⇒ $Recursion Pharmaceuticals (RXRX.US)$ merger with Exscientia
🔴 Recently Closed:
⇒ $Johnson & Johnson (JNJ.US)$ acquired V-Wave
⇒ Pharmacosmos acquired $GTHX
What companies will be next? 🤔

No comment yet